OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance
Ravinder Kumar, Vartika Srivastava
Frontiers in Fungal Biology (2023) Vol. 4
Open Access | Times Cited: 13
Ravinder Kumar, Vartika Srivastava
Frontiers in Fungal Biology (2023) Vol. 4
Open Access | Times Cited: 13
Showing 13 citing articles:
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Karolina Czajka, Krishnan Venkataraman, Danielle Brabant-Kirwan, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2655-2655
Open Access | Times Cited: 37
Karolina Czajka, Krishnan Venkataraman, Danielle Brabant-Kirwan, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2655-2655
Open Access | Times Cited: 37
Re-estimation of the burden of serious fungal diseases in Uganda
Felix Bongomin, Richard Kwizera, Martha Namusobya, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 8
Felix Bongomin, Richard Kwizera, Martha Namusobya, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 8
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in candida species isolated in africa
Chibuike Ibe, Akaninyene Otu, Carolina H. Pohl
Expert Review of Anti-infective Therapy (2025), pp. 1-14
Closed Access
Chibuike Ibe, Akaninyene Otu, Carolina H. Pohl
Expert Review of Anti-infective Therapy (2025), pp. 1-14
Closed Access
New Trends in Vaccine Characterization, Formulations, and Development
Ravinder Kumar
Vaccines (2024) Vol. 12, Iss. 3, pp. 338-338
Open Access | Times Cited: 2
Ravinder Kumar
Vaccines (2024) Vol. 12, Iss. 3, pp. 338-338
Open Access | Times Cited: 2
The Two Sides of the COVID-19 Pandemic
Ravinder Kumar, Vartika Srivastava, Kripa N. Nand
COVID (2023) Vol. 3, Iss. 12, pp. 1746-1760
Open Access | Times Cited: 6
Ravinder Kumar, Vartika Srivastava, Kripa N. Nand
COVID (2023) Vol. 3, Iss. 12, pp. 1746-1760
Open Access | Times Cited: 6
Inhibition of apoptosis and biofilm formation in Candida auris by click-synthesized triazole-bridged quinoline derivatives
Mohmmad Younus Wani, Vartika Srivastava, Waleed A. El‐Said, et al.
RSC Advances (2024) Vol. 14, Iss. 29, pp. 21190-21202
Open Access | Times Cited: 1
Mohmmad Younus Wani, Vartika Srivastava, Waleed A. El‐Said, et al.
RSC Advances (2024) Vol. 14, Iss. 29, pp. 21190-21202
Open Access | Times Cited: 1
Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum
Amir Elalouf, Hanan Maoz, Amit Yaniv Rosenfeld
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 983-983
Open Access | Times Cited: 1
Amir Elalouf, Hanan Maoz, Amit Yaniv Rosenfeld
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 983-983
Open Access | Times Cited: 1
Yeast-Based Screening of Anti-Viral Molecules
Vartika Srivastava, Ravinder Kumar, Aijaz Ahmad
Microorganisms (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access
Vartika Srivastava, Ravinder Kumar, Aijaz Ahmad
Microorganisms (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access
Adjuvant ArtinM favored the host immunity against Cryptococcus gattii infection in C57BL/6 mice
Patrícia Kellen Martins Oliveira Brito, Gabriela Yamazaki de Campos, Júlia Garcia Guimarães, et al.
Immunotherapy (2024) Vol. 16, Iss. 11, pp. 733-748
Closed Access
Patrícia Kellen Martins Oliveira Brito, Gabriela Yamazaki de Campos, Júlia Garcia Guimarães, et al.
Immunotherapy (2024) Vol. 16, Iss. 11, pp. 733-748
Closed Access
Antibiotics, Analgesic Sedatives, and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review
Angeliki Kontou, Eleni Agakidou, Ilias Chatziioannidis, et al.
Children (2024) Vol. 11, Iss. 7, pp. 871-871
Open Access
Angeliki Kontou, Eleni Agakidou, Ilias Chatziioannidis, et al.
Children (2024) Vol. 11, Iss. 7, pp. 871-871
Open Access
Vidarabine as a novel antifungal agent against Candida albicans: insights on mechanism of action
Tanjila Chandsaheb Gavandi, Sargun Tushar Basrani, Sayali Ashok Chougule, et al.
International Microbiology (2024)
Closed Access
Tanjila Chandsaheb Gavandi, Sargun Tushar Basrani, Sayali Ashok Chougule, et al.
International Microbiology (2024)
Closed Access
Role of artificial intelligence in early diagnosis and treatment of infectious diseases
Vartika Srivastava, Ravinder Kumar, Mohmmad Younus Wani, et al.
Infectious Diseases (2024), pp. 1-26
Closed Access
Vartika Srivastava, Ravinder Kumar, Mohmmad Younus Wani, et al.
Infectious Diseases (2024), pp. 1-26
Closed Access
A 14-Year Cohort of Candidemia in the Pediatric Population in a Tertiary Center in Jerusalem: Clinical Characteristics, Antifungal Susceptibility, and Risk Factors for Mortality
Maya Korem, Asher Taragin, Danna Dror, et al.
Journal of Fungi (2023) Vol. 9, Iss. 12, pp. 1171-1171
Open Access
Maya Korem, Asher Taragin, Danna Dror, et al.
Journal of Fungi (2023) Vol. 9, Iss. 12, pp. 1171-1171
Open Access
